Banner - Collaborative Care Symposium

News
Media
Conferences
Events
Publications
CME
Partners
Subscribe
Resources

Advancements in dry eye management

EP. 1: Introduction and overview of dry eye

By

November 18th 2020

EP. 2: Epidemiology and consequences of untreated dry eye

By

November 18th 2020

EP. 3: Diagnosis and overlooking asymptomatic patients with dry eye

By

November 18th 2020

EP. 4: Standard testing and assessment for dry eye disease

By

November 18th 2020

EP. 5: General principles of treatment of dry eye disease

By

November 18th 2020

EP. 6: Communication between ODs and MDs for optimal care

By

November 18th 2020

EP. 7: Review of artificial tears for dry eye

By

November 18th 2020

Eric Donnenfeld, MD, reviews the role of corticosteroids and immunomodulatory agents for the management of dry eye.

EP. 8: Corticosteroids and Immunomodulators for the treatment of dry eye

By

November 18th 2020

Eric Donnenfeld, MD, and Marguerite McDonald, MD, discuss the role of nutritional supplements as well as antibiotics in dry eye management.

EP. 9: The role of nutritional supplements and antibiotics in dry eye

By

November 18th 2020

Crystal Brimer, OD, FAAO, identifies the preferred treatment options for meibomian gland dysfunction.

EP. 10: Treating meibomian gland dysfunction

By

November 18th 2020

Crystal Brimer, OD, FAAO, shares some in-office procedures for dry eye and the patient resistance with high cost.

EP. 11: In-office procedures and patient resistance for dry eye treatments

By

November 18th 2020

EP. 12: Treatment methods for aqueous dry eye

By

November 18th 2020

EP. 13: Challenges in the management of dry eye

By

November 18th 2020

EP. 14: Counseling and formulary concerns for dry eye therapies

By

November 18th 2020

EP. 15: Overlapping diseases and the impact of COVID-19

By

November 18th 2020

EP. 16: Agents in the pipeline for dry eye disease

By

November 18th 2020

Tracy Swartz, OD, MS, FAAO, identifies some additional agents in the pipeline for the management of dry eye disease.

EP. 17: Novel agents in the pipeline for dry eye disease

By

November 18th 2020

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

Harrow completes acquisiton of Melt Pharmaceuticals

Coave Therapeutics reveals lead gene therapy program, CoTx-10

Foundation Fighting Blindness releases 4-year RUSH2A data to public

Opus Genetics doses first patient in phase 1/2 clinical trial, BIRD-1, evaluating OPGx-BEST1

Eradicating Demodex Blepharitis and Improving MGD with Lotilaner

© 2025 MJH Life Sciences^®

All rights reserved.